Michael O.
- Country
- France
- Department
- neurologie
Research Overview
- Tenecteplase plus Thrombectomy versus Thrombectomy Alone in Patients with Large Core Ischemic Stroke: A Multicentre Randomized Controlled Trial
- Efficacy of Apixaban Versus Standard Care in Patients with Intracerebral Hemorrhage: A Randomized Controlled Trial
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Asundexian for Ischemic Stroke Prevention in Adults Post-Acute Non-Cardioembolic Stroke or High-Risk TIA
Data & Insights
Has run more than one trial at 153 of 452 partner sites.
Specializations
Cerebrovascular Disorders
The investigator specializes in treating various forms of acute ischemic stroke and transient ischemic attack, with particular attention to preventive therapeutic approaches and post-stroke care.
- Stroke Prevention Strategies
- Acute Stroke Management
- Post-stroke Care
Focuses on innovative therapeutic approaches for stroke prevention and treatment in high-risk patients.
Vascular Inflammation
Demonstrates expertise in treating giant cell arteritis with cerebrovascular involvement, exploring new therapeutic options for inflammatory vascular conditions.
- Cerebrovascular Inflammation
- Arterial Disease Management
- Immunological Treatments
Specializes in combining immunological and vascular therapeutic approaches for complex arterial conditions.
Hemorrhagic Conditions
Expertise in managing intracerebral hemorrhage and developing specialized treatment protocols for patients with complex bleeding disorders affecting the brain.
- Hemorrhage Management
- Anticoagulation Strategies
- Cerebrovascular Protection
Focuses on optimizing anticoagulation approaches in patients with cerebral hemorrhage history.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.